Delivery Order SPE2DB20D3103-SPE2DB25FM9U8

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,236.16 firm fixed-price contract is for the supply of 4,557,711,596 units of Thrombin-JMI, a 20,000-unit vial medication. The award was made on July 5, 2022, with a completion date of July 6, 2022. This contract is a task order under AmerisourceBergen's larger $999,999,999 Indefinite...
This federal contract award, valued at $5,928.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 contract vehicle that enables efficient procurement of essential pharmaceutical and medical supplies for military healthcare programs globally. The contract covers the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of 20,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product, to support military healthcare programs. The award has a firm fixed price of $6,410.56 and a completion date of July 8, 2024. No set-aside designation was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,221.58 Firm Fixed Price delivery order covers the supply of 20,000 unit vials of Thrombin-JMI, a critical medication. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (parent company of Amerisourcebergen Drug Corp) holds with the DLA...
This federal contract award is for the delivery of THROMBIN-JMI 20,000 UNIT VIALS to the Defense Logistics Agency (DLA), a major defense agency responsible for logistics support to the U.S. military. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, on September 22, 2023 with a ceiling value of $6,595.68 and a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation,...
This federal contract award is for the delivery of THROMBIN-JMI 20,000 UNITS VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 1, 2021, with a ceiling value of $13,799.82 and a completion date of September 2, 2021. The contract is a Delivery Order under a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The contract is for the supply of THROMBIN-JMI 5,000 units vials, a pharmaceutical product, with a potential value of $1,001.30 and a performance period through March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous similar awards from DLA Troop Support Medical to provide...
This federal contract award, with an ID of SPE2DB20D7061|SPE2DB25FSLH8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,490.87, is for the delivery of 5,000-unit vials of the medication Thrombin-JMI. This is a firm-fixed-price delivery order contract with a completion date of November 25, 2024. The contract does not have a set-aside designation, indicating open...
This federal contract award, with ID SPE2DX15D2223|SPE2DX24F4GAN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,805.10 firm fixed price delivery order is for the supply of 5,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
This contract award is for the delivery of 20,000 unit vials of THROMBIN-JMI to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a potential value of $2,061.15. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. This award is not associated...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM9U8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 20,000 unit vials of THROMBIN-JMI, a specialty medication. The firm-fixed-price contract has a ceiling value of $26,403.22 and a period of performance through March 10, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/6/25, 9:54 AM